# Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer

> **NCT00357760** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 94 (actual)

## Conditions studied

- Metastatic Renal Cell Carcinoma

## Interventions

- **BIOLOGICAL:** VEGF Trap

## Key facts

- **NCT ID:** NCT00357760
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2017-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00357760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00357760, "Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00357760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*